Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka.

Subodha Waiddyanatha Anjana Silva Supun Wedasingha Sisira Siribaddana Geoffrey K Isbister

Published in: Clinical toxicology (Philadelphia, Pa.) (2023)

We confirmed that Indian polyvalent antivenom use in Sri Lanka is associated with high rates of acute adverse reactions. In contrast to studies of other antivenoms only a small proportion of patients developed serum sickness.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
magnetic resonance
emergency department
liver failure
risk factors
patient reported outcomes
stem cells
bone marrow
hepatitis b virus
electronic health record
patient reported